Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $245,550 | $28,823,000 | $25,169,000 | $18,667,000 |
| Short-Term Investments | $171,528 | $19,931,000 | $23,485,000 | $25,793,000 |
| Receivables | $191,605 | $27,115,000 | $29,653,000 | $32,854,000 |
| Inventory | $26,241,000 | $25,125,000 | $24,979,000 | $26,478,000 |
| Other Curr. Assets | -$26,039,322 | $4,152,000 | $3,694,000 | $2,962,000 |
| Total Curr. Assets | $810,362 | $105,146,000 | $106,980,000 | $106,754,000 |
| Property Plant & Equip (Net) | $29,762,000 | $27,535,000 | $27,069,000 | $25,967,000 |
| Goodwill | $0 | $0 | $242,000 | $0 |
| Intangibles | $13,554 | $1,970,000 | $1,652,000 | $1,859,000 |
| Long-Term Investments | $587,748 | $86,132,000 | $107,544,000 | $92,075,000 |
| Tax Assets | $496,000 | $0 | $566,000 | $0 |
| Other NC Assets | -$29,904,459 | $22,885,000 | $2,000 | $22,275,000 |
| Total NC Assets | $954,843 | $138,522,000 | $137,075,000 | $142,176,000 |
| Other Assets | $0 | $0 | $4,000 | $0 |
| Total Assets | $1,765,205 | $243,668,000 | $244,059,000 | $248,930,000 |
| Liabilities | – | – | – | – |
| Payables | $52,431 | $5,515,000 | $4,602,000 | $5,115,000 |
| Short-Term Debt | $8,585 | $1,280,000 | $1,280,000 | $1,280,000 |
| Tax Payable | $5,095,000 | $0 | $1,474,000 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | -$4,929,049 | $11,161,000 | $9,222,000 | $13,444,000 |
| Total Curr. Liab. | $226,967 | $17,956,000 | $16,578,000 | $19,839,000 |
| LT Debt | $3,380 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $95,194 | $0 | $16,481,000 | $0 |
| Other NC Liab. | $2,298 | $17,481,000 | $875,000 | $17,774,000 |
| Total NC Liab. | $100,873 | $17,481,000 | $17,356,000 | $17,774,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3,380 | $0 | $0 | $0 |
| Total Liabilities | $48,502,000 | $35,437,000 | $33,934,000 | $37,613,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $164,647 | $24,356,000 | $24,356,000 | $24,356,000 |
| Retained Earnings | $897,363 | $129,480,000 | $131,488,000 | $128,367,000 |
| AOCI | $307,891 | $44,588,000 | $43,453,000 | $47,773,000 |
| Other Equity | $59,028 | $8,662,000 | $9,706,000 | $9,706,000 |
| Total Equity | $1,428,929 | $207,086,000 | $209,003,000 | $210,202,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $8,416 | $1,145,000 | $1,122,000 | $1,115,000 |
| Total Liab. & Tot. Equity | $261,125,000 | $243,668,000 | $244,059,000 | $248,930,000 |
| Net Debt | -$233,585 | -$27,543,000 | -$23,889,000 | -$17,387,000 |